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Abstract
Understanding the pathogenesis of infection by neurotropic viruses represents a major challenge and may improve our
knowledge of many human neurological diseases for which viruses are thought to play a role. Borna disease virus (BDV)
represents an attractive model system to analyze the molecular mechanisms whereby a virus can persist in the central
nervous system (CNS) and lead to altered brain function, in the absence of overt cytolysis or inflammation. Recently, we
showed that BDV selectively impairs neuronal plasticity through interfering with protein kinase C (PKC)–dependent
signaling in neurons. Here, we tested the hypothesis that BDV phosphoprotein (P) may serve as a PKC decoy substrate when
expressed in neurons, resulting in an interference with PKC-dependent signaling and impaired neuronal activity. By using a
recombinant BDV with mutated PKC phosphorylation site on P, we demonstrate the central role of this protein in BDV
pathogenesis. We first showed that the kinetics of dissemination of this recombinant virus was strongly delayed, suggesting
that phosphorylation of P by PKC is required for optimal viral spread in neurons. Moreover, neurons infected with this
mutant virus exhibited a normal pattern of phosphorylation of the PKC endogenous substrates MARCKS and SNAP-25.
Finally, activity-dependent modulation of synaptic activity was restored, as assessed by measuring calcium dynamics in
response to depolarization and the electrical properties of neuronal networks grown on microelectrode arrays. Therefore,
preventing P phosphorylation by PKC abolishes viral interference with neuronal activity in response to stimulation. Our
findings illustrate a novel example of viral interference with a differentiated neuronal function, mainly through competition
with the PKC signaling pathway. In addition, we provide the first evidence that a viral protein can specifically interfere with
stimulus-induced synaptic plasticity in neurons.
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Introduction
The finding that persistent viruses could selectively affect
differentiated functions of their target cell without causing cell
lysis or widespread inflammation was first demonstrated more
than 25 years ago [1]. This type of viral persistence, characterized
by minimal cell damage, seems particularly well suited for the
central nervous system (CNS) given the limited capacity of renewal
of CNS resident cells, in particular of neurons. Viral interference
with selected signaling pathways will nevertheless disrupt cellular
homeostasis and cause disease [2]. As viral impairment of neurons
may lead to behavioral or cognitive impairment, it was therefore
hypothesized that persistent viruses could play a role in human
mental disorders of unclear etiology [3,4]. To date, the
mechanisms whereby viruses can interfere with brain function
are not well understood and are strongly dependent on the strategy
that a given virus has developed to persist in the CNS [5,6]. For
viruses actively replicating in neuronal cells, one hypothesis is that
the expression and/or accumulation of viral products in the cell
may affect neuronal activity and cause disease. To date, it is clear
that much is needed for a better understanding of the pathogenesis
of persistent viral infections of the CNS and for the identification
of the viral determinants responsible for the associated diseases.
Borna disease virus (BDV) is a highly neurotropic, non-cytolytic
virus that provides an ideal paradigm for studying the behavioral
correlates of CNS viral infections. BDV is an enveloped virus with
a non-segmented, negative strand RNA genome [7,8]. In contrast
to other Mononegavirales, BDV replicates in the nucleus of infected
cells [9] and uses the host cell splicing machinery for maturation of
viral transcripts [10,11]. The BDV compact genome encodes for
six proteins, namely, the nucleoprotein (N), phosphoprotein (P),
protein X, matrix protein (M), glycoprotein (G), and polymerase
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(L). Whereas M and G are involved in particle formation, P, N, L,
and X are components of the polymerase complex. BDV infects a
wide variety of mammals [12,13] and is associated with a large
spectrum of neurological disorders, ranging from immune-
mediated diseases to behavioral alterations without inflammation
[12,14,15]. These disorders are reminiscent of symptoms observed
in certain human neuropsychiatric diseases [16]. Evidence suggest
that BDV infections may also occur in humans, although a link
between BDV infection and any human neurological disease has
not been firmly established yet [17–19]. The neurobehavioral
manifestations associated with BDV infections in animals are
partly due to the selective tropism of BDV in the CNS for neurons
of the cortex and hippocampus [15,20,21], which govern many
cognitive and behavioral functions [22].
In an effort to better characterize the impact of BDV persistence
on neuronal function, we recently analyzed the neuronal activity of
primary cultures of neurons infected with BDV, using both
functional imaging and electrophysiological approaches [23,24].
These studies clearly showed that BDV interferes with activity-
dependent plasticity, while leaving the basal properties of neuronal
activity unaffected. Moreover, the selective impairment of neuronal
plasticity due to BDV infection was correlated to a reduced
phosphorylation of the neuronal targets of Protein Kinase C (PKC),
a kinase that plays important roles in the regulation of neuronal
activity [25]. Amongst the different viral proteins, BDV P appeared
as the most plausible candidate for mediating this interference.
Similar to the phosphoproteins of other Mononegavirales, BDV P is a
component of the viral polymerase complex, which serves several
functions in the viral life cycle. These functions are thought to be
regulated, at least in part, by its phosphorylation by cellular kinases
[26]. BDV P is preferentially phosphorylated at serine residues 26
and 28 by PKC and, to a lesser extent, at serine residues 70 and 86
by casein kinase II (CKII) [27]. Taken together, these observations
led us to postulate that BDV P may serve as a PKC kinase decoy
substrate when expressed in neurons, resulting in the decreased
phosphorylation of other PKC neuronal targets. Although trans-
fection experiments using a BDV P expressing plasmid provided the
first evidence that this could indeed be the case [24], a formal
demonstration of the role of BDV P in PKC-dependent signaling
and on neuronal activity was needed.
The newly established reverse genetics technique allowing the
generation of recombinant BDV (rBDV) entirely from cDNA has
provided means to test this hypothesis directly [28]. Recently, we
characterized rBDV expressing P mutants lacking either the PKC
or the CKII phosphorylation sites, upon replacement of the
corresponding serine residues with alanines to abrogate phosphor-
ylation [29]. We showed that phosphorylation of BDV P acts as a
negative regulator of the viral polymerase complex activity, in
contrast to what has been shown for other Mononegavirales. Here,
we infected primary cultures of rat hippocampal and cortical
neurons with these different recombinant viruses and analyzed
their phenotype and responses to stimulation. Using a rBDV
where P can no longer be phosphorylated by PKC, we
demonstrate a complete suppression of viral interference with
neuronal activity. This was shown not only at the molecular level
in terms of PKC-dependent signaling, but also at the functional
level by studying calcium responsiveness to depolarization and the
electrophysiological network properties of cultured neurons.
Thus, our findings illustrate a novel example of viral
interference with a differentiated neuronal function, mainly
through competition with the PKC signaling pathway. In addition,
we provide the first evidence that a viral protein can specifically
interfere with stimulus-induced synaptic plasticity in neurons.
Results
Characterization of the mutant viruses in primary
hippocampal neuronal cultures
To study the impact of BDV P phosphorylation on viral
neuropathogenesis, we used a recombinant BDV in which the two
serine (S) residues in position 26 and 28 of P have been replaced by
alanine (A) residues (rBDV-AASS). We have previously shown that
these mutations, when introduced using the recently established
technique for generating BDV from cDNA [28], completely
abolishes BDV P phosphorylation by PKC, while still supporting
full polymerase activity and viral growth [27,29]. As a control, we
also used a recombinant wild-type BDV (rBDV-wt), composed of
the canonical sequence of wild-type BDV strain He/80 [30].
We first analyzed the impact of these mutations on the kinetics
of viral spread in primary hippocampal rat neuronal cultures. To
this end, we infected neuron-rich cultures (.80% neurons) one
day after their plating with 300 focus forming units (FFU) per well
of either rBDV-wt or rBDV-AASS cell-released virus (prepared
from persistently infected Vero cells). We studied viral dissemina-
tion occurring after primary infection by assessing expression of
the BDV nucleoprotein at different times post-infection, using
immunofluorescence microscopy to quantify viral spread. Consis-
tent with our previous reports using wild-type BDV [31], infection
with rBDV-wt was apparent by 5 to 7 days post-infection, with a
low percentage (,10%) of all neurons being positive for BDV
nucleoprotein. The virus spread rapidly increased thereafter and
by day 20, more than 95% of neurons were infected (Figure 1A).
In contrast, spread of the rBDV-AASS virus was significantly
delayed, in particular between days 10 and 17 post-infection, a
time when viral dissemination speed is usually maximal due to the
increased density of the neuronal network [31]. Thus, the
phosphorylation of BDV P seems to be required for optimal
transneuronal virus spread in primary neurons.
Importantly, despite the delayed kinetics for rBDV-AASS,
infection ultimately disseminated to the whole neuronal cultures.
By 20–21 days post-infection, the large majority of neurons was
positive for BDV antigens, with no significant differences between
Author Summary
Neurotropic viruses have evolved diverse strategies to
persist in their host, with variable consequences for brain
function. The investigation of these mechanisms of
persistence and associated disease represent a major issue
in viral pathogenesis, as it may also improve our
understanding of human neurological diseases of unclear
etiology for which viruses are thought to play a role. In this
study, we have examined the mechanisms whereby the
neurotropic Borna disease virus (BDV) can selectively
interfere with synaptic plasticity upon infection of neurons.
Using genetically engineered recombinant viruses, we
show that the phosphorylation of BDV phosphoprotein (P)
by the cellular protein kinase C (PKC) is the main
determinant for this interference, mainly by competing
with the phosphorylation of the natural PKC substrates in
neurons. A mutant virus in which the PKC phosphorylation
site of P has been destroyed no longer interferes with this
signaling pathway. As a result, the calcium dynamics and
electrical activity in response to stimulation of neurons
infected with this mutant virus are completely corrected
and become similar to that of non-infected neurons. Thus,
our findings uncover a previously undescribed mechanism
whereby a viral protein interferes with neuronal response
to stimulation.
BDV P Blocks PKC Neuronal Signaling
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cultures infected with either rBDV-wt or rBDV-AASS, as assessed
by immunofluorescence analysis (Figure 1B). At this stage,
quantitative Western blot analysis revealed that comparable
amounts of N, P and X viral proteins were present in neurons
infected with both rBDV-wt and rBDV-AASS viruses. Consistent
with our previous characterization of rBDV-AASS, we observed a
delayed migration for the X protein [29], presumably resulting
from the two amino acids substitutions introduced in X when
generating the rBDV-AASS mutant.
In conclusion, both recombinant viruses were able to infect the
totality of our neuronal cultures, albeit with a delayed kinetics for
rBDV-AASS. For our subsequent signaling and functional studies,
we therefore used neurons that had been infected for at least
21 days and verified for each experiment that infection was indeed
complete prior to any subsequent analysis.
The S26/28A mutation of BDV P corrects the interference
with PKC signaling
Recently, we have shown that BDV-induced impairment of
potentiation of synaptic activity was due to an interference with
the PKC-dependent phosphorylation of synaptic proteins that
modulate neuronal activity [24]. To determine the impact of the
destruction of the PKC phosphorylation sites on BDV P, we
directly stimulated the PKC pathway of neurons using the phorbol
ester PMA and analyzed the phosphorylation status of two major
PKC targets in neurons, myristoylated alanine-rich C kinase
substrate (MARCKS) and synaptosomal-associated protein of
25 kDa (SNAP25) [32,33]. Consistent with our previous reports,
we showed by quantitative Western blot analysis that the
phosphorylation of these two neuronal PKC targets was
significantly impaired in neurons infected with rBDV-wt
(Figure 2A and 2B). In contrast, there was a complete restoration
of phospho-MARCKS and phospho-SNAP25 levels in neurons
infected with rBDV-AASS, with levels being comparable to those
observed in non-infected neurons following PKC stimulation.
Analysis of calcium responsiveness to depolarization in
neurons infected with rBDV-wt and rBDV-AASS
SNAP25 is a synaptic protein that plays an essential role in
neurotransmitter release through regulation of synaptic vesicle
exocytosis [34]. In addition, SNAP-25 also modulates calcium
dynamics in response to depolarization by acting on Voltage-Gated
Calcium Channels (VGCC). It has recently been shown that activity-
dependent phosphorylation of SNAP-25 is mediated by PKC and is
required for negative regulation of VGCCs [35]. Indeed, PKC
phosphorylation of SNAP-25, by promoting inhibition of VGCCs
decreases calcium signaling and controls neuronal excitability. This
led us to investigate whether the differences observed between
neurons infected with rBDV-wt and rBDV-AASS in the phosphor-
ylation of SNAP25 would have an impact on their calcium
responsiveness upon depolarization. We therefore analyzed the
kinetics of calcium changes in response to depolarization after
exposure of infected and control neurons to 50 mMKCl. Infection of
neurons with rBDV-wt significantly enhanced their response to
depolarization, with a peak calcium response being about fifty
percent stronger than control non-infected neurons. In sharp
contrast, the calcium response of neurons infected with rBDV-AASS
was similar to that of non-infected neurons (Figure 3A and 3B).
Together, these findings suggest that BDV mediated interference
with PKC-dependent phosphorylation, by reducing phospho-SNAP-
25 levels, leads to calcium hyper-responsiveness and that mutation of
the BDV P phosphorylation sites restores normal calcium responses.
Mutations of the overlapping X protein in rBDV-AASS are
not involved in viral interference with PKC-dependent
signaling
Since P is expressed from a bicistronic mRNA encoding P and
X, the introduced mutation into the open reading frame of P in
Figure 1. Characteristics of rBDV infection of primary cultures of
hippocampal neurons. (A) Quantification of virus spread. On different
days of culture, percentages of BDV positive neurons were assessed by
immunofluorescence using an N-specific antiserum, relative to the total
number of nuclei. This measure was carried out on two replicate wells for
each time point, after random selection of five different fields for each
replicate. Results are expressed as mean6s.e.m. of four independent
experiments. *, p,0.05; **, p,0.01 by unpaired t-test. (B) Immunoflu-
orescence analysis of neurons infected with the rBDV-WT and rBDV-AASS
viruses, 21 days post-infection. BDV-N was detected with a rabbit
polyclonal antibody, followed by a FITC-labeled secondary antibody
(green), while nuclei are stained with DAPI (blue). Original magnification,
6200. (C) Western blot analysis of neuronal extracts from cultures
infected the rBDV-WT and rBDV-AASS viruses, 21 days post-infection,
using antibodies specific for the BDV N, P and X proteins. ß-Tubulin was
detected as a control reaction for equal loading of each lane. Results are
representative of four independent experiments.
doi:10.1371/journal.ppat.1000425.g001
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the rBDV-AASS mutant also resulted in two amino acid
substitutions in the X protein (Figure 4A). We previously showed
that these mutations had no impact on X binding efficiency to P or
its ability to interfere with the polymerase activity [29]. However,
we wanted to exclude formally the possible contribution of the X
mutations in the phenotype of the rBDV-AASS mutant. To
explore the importance of BDV-P phosphorylation in the presence
of wild-type X, we generated a new recombinant BDV, in which
S26 and S28 of BDV P were substituted with leucine residues
(rBDV-LLSS, Figure 4A). Similar to rBDV-AASS, viral spread of
rBDV-LLSS was delayed upon infection of hippocampal neurons
(Figure 4B). Likewise, we also demonstrated the restoration of
phospho-MARCKS and phospho-SNAP25 levels in neurons
infected with rBDV-LLSS, with levels being comparable to those
observed in non-infected neurons following PKC stimulation
(Figure 4C). Finally, the calcium hyper-responsiveness observed in
rBDV-wt infected neurons was also corrected in neurons infected
with rBDV-LLSS (Figure 4D). Thus, the phenotype observed with
rBDV-LLSS is very similar to rBDV-AASS, providing additional
evidence that our findings are indeed due to phosphorylation of
BDV-P by PKC and not to the mutations present in X.
The S26/S28A mutation of BDV P corrects the defects in
electrical activity observed in rBDV-wt infected neurons. Given
the dramatic consequences of the S26/28A mutation on neuronal
signaling and calcium responsiveness, we next studied its impact
on the electrophysiological properties of infected neurons.
Recently, we described a cell culture system using microelectrode
arrays (MEA), which allows to monitor the firing pattern of a
neuronal network grown on a grid of sixty electrodes embedded in
a culture dish (Figure 5A) [36,37]. Using this system, we showed
that BDV selectively blocks activity-dependent enhancement of
neuronal network activity, one form of synaptic plasticity thought
to be important for learning and memory [23,38]. Given the
central role of PKC in synaptic plasticity, we hypothesized that this
defect could be linked to BDV interference with this signaling
pathway. To test this hypothesis, we compared the electrophys-
iological properties of cultures of cortical neurons infected with
rBDV-wt or rBDV-AASS viruses, using the MEA culture system.
All experiments were again performed at day 21, to allow
spreading of both viruses to the totality of the MEA cultures. At
this time point, neurons have developed a rich network of
processes and form numerous functional synaptic contacts [31,39].
In agreement with our previous results [23], we did not observe
any significant difference in the spontaneous network firing activity
between neurons infected with either rBDV-wt or rBDV-AASS
viruses (Figure 5B). This firing pattern was also indistinguishable
from that of control non-infected neurons. Next, we induced
increased synaptic efficacy by exposing neuronal cultures for
15 min to 50 mM of bicuculline, a GABAA receptor antagonist.
Treatment with this antagonist leads to the removal of the tonic
inhibition imposed by GABAergic interneurons on the network
[40]. As a result, we observed a significant increase of the mean
burst frequency, which shifted from 0.175 Hz to 0.285–0.31 Hz
(Figure 5B). Here again, the behavior of all neuronal cultures was
remarkably similar, regardless of their infection status. Interest-
ingly, the increase in the strength of the synaptic connections
Figure 2. Analysis of PKC signaling in hippocampal neurons infected with the different recombinant viruses. Total extracts were
prepared from non-infected (NI) neurons and neurons infected with the rBDV-WT or rBDV-AASS viruses (21 days post-infection), after stimulation or
not with 1 mM PMA for 10 min. Equivalent protein amounts were analyzed by Western blot with specific antibodies for (A) phospho-MARCKS
(pMARCKS; PKC site at Ser152/156) and (B) phospho-SNAP-25 (pSNAP-25, PKC site at Ser187). ß-tubulin and total MARCKS and SNAP-25 were used to
normalize expression. Bottom graphs show the fluorometric quantification, using the Odyssey imager, of four to ten independent experiments.
Quantification results were expressed as percentage of increase relative to the response of NI neurons, which was set at 100%. Values are expressed
as mean6s.e.m. *, p,0.05; **, p,0.01; ***, p,0.001 by unpaired t-test.
doi:10.1371/journal.ppat.1000425.g002
BDV P Blocks PKC Neuronal Signaling
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triggered by bicuculline lasts for several hours upon removal of the
drug [40,41] and is thought to represent the cellular basis of
learning and memory [38]. In non-infected neurons, we indeed
observed this maintenance of a high level of network activity,
lasting more than two hours after washout of the drug. In contrast,
neurons infected with rBDV-wt had returned to basal levels of
network activity already one hour after bicuculline washout,
confirming our previous results using wild-type BDV [23]. Very
strikingly, the network properties of neurons infected with rBDV-
AASS were completely different, as we observed the maintenance
of high levels of synaptic activity persisting up to two hours after
bicuculline washout, similarly to non-infected neurons. Therefore,
a recombinant BDV which can no longer be phosphorylated by
PKC on its mutated P protein has lost its capacity to block activity-
induced synaptic potentiation.
Discussion
The goal of our study was to provide further information about
the mechanisms whereby BDV infection of neurons selectively
interferes with synaptic plasticity and to identify the viral
determinant responsible for this interference. Using a recombinant
virus in which the PKC phosphorylation sites of BDV P protein
have been destroyed, we demonstrate that primary cultures of
neurons infected with this recombinant virus exhibit a behavior
that becomes indistinguishable in many aspects to that of control,
non-infected neurons. Therefore, our results clearly establish that
BDV interference with PKC signaling, but also with calcium
responses to depolarization and with network electrical properties,
all result from the competition mediated by P with the
phosphorylation of endogenous PKC substrates in neurons. We
therefore propose a pathogenesis mechanism by which BDV
would use PKC-dependent phosphorylation of P for its optimal
spread in neurons, at the expense of an impaired response to
potentiation stimuli of the infected neurons (Figure 6). Our
findings provide strong evidence for a novel mechanism whereby a
viral protein selectively blocks neuronal plasticity, representing a
fascinating aspect of viral interference with neuronal functioning.
Interestingly, both mutant viruses rBDV-AASS and rBDV-
LLSS were strongly delayed in its capacity to spread within the
neuronal cultures. These findings suggest that PKC-dependent
phosphorylation of P is an important parameter for efficient
transmission of BDV from neuron to neuron. This may also
explain the preferential BDV infection of CNS regions where
PKC activity is high, such as hippocampus [42]. The underlying
mechanism for this delayed spread is unclear and it is presently not
possible to discriminate whether it is due to reduced cell-to-cell
transmission or to a reduced capacity of the virus to be transported
along neuronal processes. It does not seem to result from a
Figure 3. Calcium responses recorded from hippocampal
neurons infected with the rBDV-WT and rBDV-AASS viruses.
(A) Representative example of a time-course measurement of free
intracellular calcium by microspectrofluorimetry. Fluo-3 loaded neuronal
cultures were recorded over a 250 second-period (1 measure per second)
upon (1) exposure to 50 mM KCl; (2) treatment with thapsigargin/
ionomycin in the presence of 10 mM EGTA to record the minimum
fluorescence; (3) stimulation with 120 mM CaCl2 (a concentration
sufficient to chelate EGTA), allowing the recording of the maximum
fluorescence. (B) Representative example of the peak calcium responses
following depolarization with 50 mM KCl of control neurons (NI) and
neurons infected with rBDV-WT or rBDV-AASS viruses. Data were plotted
on the same graph for comparison. (C) Quantitative analysis of peak
calcium responses. In each case, recordings were performed on six
separate wells, and data represent the mean of four independent
experiments. [Ca2+]i increase was expressed as the increase in
fluorescence signal after stimulation relative to the increase measured
in NI neurons, which was set at 100%. *, p,0.05 by unpaired t-test.
doi:10.1371/journal.ppat.1000425.g003
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decreased efficacy of viral replication, since analysis of the steady
state levels of viral transcripts in rBDV-AASS- as well as in rBDV-
LLSS-infected cells appeared to be normal [29]. It could be due to
a less efficient transport of BDV ribonucleoparticles along the
neuronal processes, resulting from impaired interaction of non-
phosphorylated P with yet unidentified neuronal motor proteins
involved in BDV trans-neuronal spread. Alternatively, the delayed
spread may be a consequence of impaired virus assembly or
release, similar to human respiratory syncytial virus, where
phosphorylation of P regulates the viral budding process by
blocking the interaction of P with the viral matrix protein [43].
Finally, mutations present in the X protein should also be taken
into account, as we cannot exclude the possibility that these
mutations may affect unknown functions of X, leading to impaired
viral spread. However, this latter possibility seems unlikely as the
rBDV-LLSS mutant, which has no mutation in X, also exhibits
delayed spread kinetics in neurons.
Infection with the rBDV-AASS virus led to a complete
restoration of the PKC-dependent phosphorylation of two
neuronal targets that play crucial roles in modulating neuronal
plasticity. Indeed, phosphorylation of MARCKS by PKC is
implicated in actin-dependent cytoskeletal plasticity [44] and in
the maintenance of long-term potentiation in vivo [45]. SNAP-25 is
not only central for neuronal exocytosis but also for the regulation
Figure 4. Phenotypic characterization of a recombinant BDV (RBDV-LLSS) bearing mutations in the PKC phosphorylation site of P
(S26L;S28L), but none in the overlapping X protein. (A) Cartoon depicting part of the P and X overlapping open reading frames of the 0.8 kb
mRNA from the indicated viruses and their translation products. Amino acids and nucleotides highlighted in red indicate differences from the wild-
type situation. (B) Comparative analysis of virus spread for rBDV-wt, rBDV-AASS and rBDV-LLSS recombinant viruses. Percentages of BDV positive
neurons were assessed by immunofluorescence on different days of culture, as described in Figure 1. This measure was carried out on two replicate
wells for each time point, after random selection of five different fields for each replicate. Results are expressed as mean6s.e.m. of three independent
experiments. (C) Analysis of PKC signaling in hippocampal neurons. Total extracts were prepared from non-infected (NI) neurons and neurons
infected with the rBDV-WT or rBDV-LLSS viruses (21 days post-infection), after stimulation or not with 1 mM PMA for 10 min. Equivalent protein
amounts were analyzed by Western blot with specific antibodies for phospho-MARCKS and phospho-SNAP-25. ß-tubulin was used to normalize
expression. Bottom graphs show the fluorometric quantification, using the Odyssey imager, of one representative experiment out of three.
Quantification results were expressed as percentage of increase relative to the response of NI neurons, which was set at 100%. (D) Quantitative
analysis of peak calcium responses recorded from hippocampal neurons infected with the rBDV-WT and rBDV-LLSS viruses. In each case, recordings
were performed on six separate wells, and data represent results of a representative experiment out of two. [Ca2+]i increase was expressed as the
increase in fluorescence signal after stimulation relative to the increase measured in control neurons, which was set at 100%.
doi:10.1371/journal.ppat.1000425.g004
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of calcium responsiveness. Modulation of neuronal excitability by
SNAP-25, which is dependent on PKC, is thought to have crucial
consequence for brain functioning [34]. The calcium hyper-
excitability in response to depolarization that we observed after
infection with rBDV-wt is consistent with a recent study showing
that non-phosphorylable (S187A) SNAP-25 mutants also display
increased calcium responsiveness [35]. Moreover, SNAP-25
S187A mutant mice exhibit behavioral abnormalities and
hyperlocomotor activity, similar to what has been described
following BDV infection [46]. Finally, genetic studies have
demonstrated an association of polymorphisms in the human
SNAP-25 gene with attention deficit hyperactivity disorder or
cognitive performance [47,48]. Nevertheless, as BDV is likely to
affect all PKC neuronal substrates in the infected neurons, the
relative contribution of the decreased phosphorylation of each of
these substrates, including SNAP-25, is difficult to appreciate.
Very striking was the impact on the neuronal electrical activity
measured using the MEA system. Since neurons infected with the
rBDV-AASS mutant displayed a response to bicuculline stimula-
tion that became indistinguishable from that of non-infected
neurons, it is likely that interference with PKC signaling is indeed
a main determinant for BDV impairment of neuronal functioning.
The question remains open of whether the impairment of
neuronal activity due to BDV infection is solely dependent on
PKC inhibition. Using a global proteomic approach, we recently
demonstrated that other neuronal pathways were altered by BDV
infection, even prior to any stimulation [49]. At present, the link
between some of these pathways, such as chromatin dynamics or
transcriptional regulation and PKC-dependent signaling is not
clear. Using infection with rBDV-AASS, in which PKC
interference is suppressed, will be instrumental to test whether
these other pathways are still affected, allowing to gain further
insight on the relationship between the different BDV targets in
neurons.
Phosphoproteins of non-segmented negative-strand RNA virus-
es are subunits of the viral polymerase complex and are all
phosphorylated by host kinases [26]. Although many studies have
addressed the role of P phosphorylation on the virus life cycle, very
few have tested its consequences on the physiology of the target
cell. In theory, other viral phosphoproteins could also block
endogenous phosphorylation, including that of PKC. For example,
it has been shown that rabies P can be phosphorylated by PKC
[50]. However, BDV represents a unique example where neurons
can be persistently infected with strong antigenic load and no
widespread cytolysis. Thus, a possible interference with PKC-
dependent phosphorylation in neurons becomes apparent follow-
ing BDV infection due to its outstanding non-cytolytic replication
strategy, whereas it would not be detected with other viral systems
that kill their target cell within a few days.
As for the other Mononegavirales, BDV P is a multifunctional
protein, which plays many roles in the virus life cycle. Besides its
interference with PKC signaling, P has been reported to influence
cellular functions at different levels. In particular, recent studies
revealed interactions of P with a neurite outgrowth factor,
amphoterin/HMG-1 [51], with the Traf family member-associ-
ated NF-kB (TANK)-binding kinase-1 (TBK-1) [52] and the
gamma-aminobutyric acid receptor-associated protein [53]. Since
these studies were based on transient transfection using non-
Figure 5. Analysis of the electrophysiological properties of
neurons infected with the different recombinant viruses. (A)
Representative view of cortical neurons cultured in an MEA dish.
Electrodes are spaced by 200 mm; electrode diameter is 30 mm. Original
magnification, 650. (B) Quantitative analysis of the mean burst
frequency for non-infected (NI) neurons and neurons infected with
the rBDV-WT or rBDV-AASS viruses (21 days post-infection). The mean
burst frequency was calculated under spontaneous conditions (spont),
bicuculline stimulation (bic), as well as 1 h and 2 h after bicuculline
washout. For each condition, data were acquired from 170 to 311
electrodes, from four independent experiments using four MEA dishes
for each mock or virus infection. Values are expressed as mean6s.e.m.
***, p,0.001 by unpaired t-test.
doi:10.1371/journal.ppat.1000425.g005
Figure 6. A model of P-mediated interference with PKC-
dependent signaling and neuronal plasticity. Diverse potentia-
tion stimuli will trigger activation of many kinases, including PKC. In
cells infected with rBDV-WT (left), this will lead to enhanced
phosphorylation of P, optimal viral spread and concomitant decreased
activation of endogenous PKC substrates (among which MARCKS and
SNAP-25), ultimately leading to impairment on neuronal plasticity. In
neurons infected with rBDV-AASS (right), mutated P does not interfere
with PKC-dependent signaling and neuronal plasticity is restored.
However, lack of phosphorylation of P leads to viral attenuation.
doi:10.1371/journal.ppat.1000425.g006
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neuronal cells, the relevance of these findings for BDV
pathogenesis remains elusive and awaits further confirmation. It
has also been shown that the expression of P in glial cells of
transgenic mice leads to behavioral abnormalities [54], although
the underlying mechanism was not identified. Given the important
role of astrocytes in the regulation of neuronal activity [55], one
hypothesis could be that P could also interfere with PKC-signaling
in astrocytes and thereby disrupt glia-neuron communication.
Interestingly, MARCKS, the main PKC substrate, is also
expressed in astrocytes [56]. Finally, the two phospho-serine
residues of P in themselves could have other unknown effects that
could contribute to the phenotype observed, besides acting as
PKC decoy substrates. Although none of the other known
functions of P were affected, there may still be other uncharacter-
ized functions of P that may be involved in the regulation of
neuronal activity.
To date, the analysis of the mechanisms underlying viral
interference with neuron-specific differentiated functions, partic-
ularly those that support synaptic activity has been hampered by
the lack of suitable model systems and easily testable hypotheses.
BDV infection has provided considerable new insight on these
issues, and the recent availability of a reverse genetics system has
offered a powerful tool to assess directly the role of individual viral
proteins in virus-host interplay and pathogenicity. Our data
unambiguously demonstrate the role of P as a decoy substrate
interfering with PKC signaling pathway, a kinase which plays
important roles in learning and behavior [25]. Moreover, they
reveal an original strategy for a neurotropic persistent virus and
provide clues to better understand the basis of neuronal
impairment caused by BDV. It will be important in the future
to test the impact of BDV P in vivo, either using animal models for
BDV infection or expressing the wild-type and mutant forms of P
in selected brain areas.
Materials and Methods
Primary culture of neurons and viral infections
Hippocampal neurons were prepared from newborn Sprague-
Dawley rats and maintained in Neurobasal medium (Invitrogen,
Cergy-Pontoise, France) supplemented with 0.5 mM glutamine,
1% fetal calf serum, 1% Penicillin/Streptomycin and 2% B-27
supplement (Invitrogen), as described [31,57]. Neuronal cultures
contained more than 80% neurons, as assessed by staining with
the neuron-specific markers MAP-2 or ß-III Tubulin (data not
shown). Neurons were infected one day after plating with cell-free
BDV. Cell-released virus stocks were prepared as described
[31,57], using Vero cells persistently infected with the different
recombinant viruses. BDV infection of neurons was verified by
immunofluorescence for each experiment.
Antibodies and reagents
We used: mouse monoclonal antibodies to SNAP25 (Synaptic
Systems, Goettingen, Germany), ß-tubulin (Sigma-Aldrich, Lyon,
France), rabbit polyclonals to phospho-MARCKS (Ser152/156, a
site specifically phosphorylated by PKC; Cell Signaling Technol-
ogy, Danvers, Massachusetts, USA), MARCKS (Chemicon-
Millipore, Saint-Quentin-en-Yvelines, France). Phospho-SNAP25
(Ser187) antibody, a site specific for PKC phosphorylation [33]
was kindly provided by Pr. M. Takahashi (Kitasato-University
School of Medicine, Kitasato, Japan). All other antibodies have
been described elsewhere [57]. Pharmacological agents were used
at the following final concentrations: 1 mM PMA, 1 mM
tetrodotoxin (TTX; Sigma-Aldrich), 100 mM of NMDA receptor
blocker D-(-)-2-amino-5-phosphopentanoic acid (APV) and
40 mM of AMPA/kainate receptor blocker 6-cyano-7-nitroqui-
noxaline-2,3-dione disodium (CNQX; Tocris Bioscience, Bristol,
United Kingdom). Bicuculline (Bicuculline methiodide, Tocris
Biosciences) was used at a final concentration of 50 mM.
Plasmid construction
To introduce point mutations into the P gene of the full-length
BDV genome (pBDV-LLSS), assembly PCR using the plasmid
pBRPolII-HrBDVc as a template was carried out as described
[29].
Immunofluorescence
Standard immunofluorescence was performed as described
previously [49]. Briefly, cells grown on glass coverslips were fixed
for 20 min at room temperature with 4% paraformaldehyde,
permeabilized using PBS+0.1% Triton-X100 during 4 min, rinsed
with PBS, and blocked overnight at 4uC with PBS+2% normal
goat serum. Incubation for 1 h at room temperature or overnight
at 4uC with primary antibodies was followed, after several washes
in PBS, by a 1-h incubation at room temperature with secondary
antibodies. After extensive washing, coverslips were mounted by
using Vectashield containing DAPI to stain nuclei (Vector
Laboratories, Burlingame, CA).
Stimulation of neuronal cultures, cell extracts and
Western blot
Neurons were incubated for 60 min at 37uC in culture medium
containing the blockers of neuronal activity TTX, APV and
CNQX. Following this resting period, the medium was replaced by
medium containing 1 mM PMA and neurons were stimulated for
10 min. Neurons were then rapidly washed in ice-cold PBS and
harvested in lysis buffer containing phosphatase inhibitors [57]. The
rest of the procedure was performed as described [49]. Briefly,
equivalent amounts of cell lysates were separated by electrophoresis
using 10% Bis-Tris Nu-PAGE gels (Invitrogen) and then transferred
onto nitrocellulose membranes (Hybond-C extra, Amersham
Biosciences, Orsay, France). After blocking (Li-Cor blocking buffer,
ScienceTec, Les Ulis, France, or Tris buffer saline containing 5%
non-fat dry milk), membranes were incubated with primary
antibodies. Secondary fluorescent antibodies used were the
following: IRDye 800CW goat anti-Mouse IgG (Li-Cor) or Alexa
Fluor 680 goat anti-rabbit IgG (Invitrogen). Laser scanning and
quantitative analyses of the blots were performed using the Odyssey
Infrared Imaging System (Li-Cor). Quantification of protein
phosphorylation was carried out by measuring the intensity of
fluorescence of the band corresponding to the phosphorylated
protein normalized by ß-tubulin expression, due to inefficient
stripping of phospho-MARCKS and phospho-SNAP-25 antibodies
binding. In parallel, total levels for each protein was verified on a
separate blot. Results are expressed as percentage of increase over
the mean of unstimulated controls, which was set to 100%.
Free intra-cellular calcium measurements
Neurons grown on flat-bottom 96-well plates were incubated for
30 min at 37uC in HBSS (Invitrogen) –BSA (Sigma) solution
containing 2.5 mM probenecid (Sigma), pH 7.45 supplemented
with fluo-3 acetoxymethyl (AM) 1 mM (Invitrogen) and 20%
pluronic F-17 (Sigma). After this incubation period, neurons were
washed twice with HBSS-BSA-probenecid solution and placed
into a 37uC incubator in the dark for 30 min. Fluorescence was
measured at 460–490 nm excitation and 515 nm emission in each
well, using a Novostar plate reader (BMG Labtech, Champigny s/
Marne, France). For each well, a series of 250 recordings (one per
BDV P Blocks PKC Neuronal Signaling
PLoS Pathogens | www.plospathogens.org 8 May 2009 | Volume 5 | Issue 5 | e1000425
second) was performed; neurons were first exposed to 50 mM KCl
(Sigma) from 10 to 90 s, then to HBSS-BSA-probenecid solution
containing 50 mM thapsigargin (Calbiochem, Fontenay-sous-Bois,
France), 5 mM ionomycin (Calbiochem) and 10 mM EGTA
(Sigma) from 90 to 177 s and finally to HBSS-BSA-probenecid
solution containing 120 mM CaCl2 from 177 to 250s. [Ca2
+]i was
calculated using the equation [Ca2+]i =Kd (F2Fmin)/(Fmax2F),
where Kd is the dissociation constant of the Ca
2+-fluo-3 complex
(390 nM), and F represents the fluorescence intensity of the cells
expressed as the ratio between the highest fluorescence measure-
ment between 10 and 90 s and the baseline. Fmin corresponds to
the minimum fluorescence between 90 and 177 s. Fmax represents
the maximum fluorescence between 177 and 250 s (see Figure 3A).
Electrophysiology
Neuronal cortical cultures were prepared from embryonic
Sprague Dawley rats at gestational day 18, according to a
previously described protocol [37]. Neurons were seeded at a
density of 105 cells per MEA and half of the MEA dishes were
infected with BDV on day 1. All experiments were made on day 21,
to allow spreading of the different recombinant viruses to the totality
of the MEA dishes. Signals corresponding to the electrical activity
from the 60 electrodes of the MEA were recorded using the MC
Rack Software (Multi Channel Systems GmbH, Reutlingen,
Germany) for online visualization and raw data storage. The signal
corresponding to the firing of a single action potential by a neuron in
the vicinity of an electrode was identified as a spike. We also
detected high frequency grouped spikes trains, known as bursts,
which represent an important parameter of the analysis of neuronal
network activity [58]. Spikes and bursts were detected by a
dedicated analysis software developed at INSERM U862 (Bor-
deaux, France) [37], which computes the signal obtained from the
electrodes, calculates a threshold and detects a spike every time the
signal crosses this threshold with a negative slope. The threshold was
set to a minimum of three standard deviations of the average noise
amplitude computed over the whole recording and applied from the
signal averaged value as a baseline [59]. Bursts were defined as a
series of $3 spikes occurring in less than 100 ms. Measures were
performed under spontaneous conditions, during a 15 min
stimulation period using 50 mM Bicuculline, and after washout of
bicuculline upon perfusing the MEA dish with 2.5 ml medium.
After each manipulation, neurons were allowed to rest for 2 min
before recordings were taken, to avoid vehicle effects. For each
condition, recordings were performed over a 3 min period, and the
mean burst frequency was calculated by averaging the results
obtained for all electrodes.
Data analysis
Data are presented as mean6standard error of the mean
(s.e.m). Statistical significance was determined using Student’s
unpaired t-test.
Accession numbers
The SwissProt (http://www.expasy.org/sprot/) accession num-
bers for proteins mentioned in the text are BDV Nucleoprotein
(Q01552), BDV Phosphoprotein (P26668), BDV X protein
(Q912Z9), BDV matrix protein (P52637), BDV polymerase
(P52639), MARCKS (P30009), SNAP-25 (P60881), PKC epsilon
(P09216), CKII (P19139), TBK-1 (Q9WUN2). The GenBank
(http://www.ncbi.nlm.nih.gov/Genbank) accession number for
the strain discussed in this paper is BDV strain He/80/FR
(AJ311522).
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